Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A2 | P19784 | 8/20 | 0.65 |
| ▸ | CSNK2B | P67870 | 8/20 | 0.65 |
| ▸ | CSNK2A1 | P68400 | 8/20 | 0.65 |
| ▸ | CYP1A1 | P04798 | 11/20 | 0.52 |
| ▸ | CYP1B1 | Q16678 | 11/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24046858 | 0.90 | CSNK2A2 (0.57) | CSNK2A2CSNK2BCSNK2A1CYP1A1CYP1B1 | |
| SCHEMBL24046883 | 0.85 | CSNK2A2 (0.51) | CSNK2A2CSNK2BCSNK2A1CYP1A1CYP1B1 | |
| SCHEMBL24047004 | 0.81 | CSNK2A2 (0.51) | CSNK2A2CSNK2BCSNK2A1CYP1A1CYP1B1 | |
| SCHEMBL24046874 | 0.80 | CSNK2A2 (0.46) | CSNK2A2CSNK2BCSNK2A1CYP1A1CYP1B1 | |
| SCHEMBL30319788 | 0.79 | CSNK2A2 (1.00) | CSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL24046990 | 0.77 | CSNK2A2 (0.50) | CSNK2A2CSNK2BCSNK2A1CYP1A1CYP1B1 | |
| SCHEMBL24046896 | 0.76 | CSNK2A2 (0.57) | CSNK2A2CSNK2BCSNK2A1CYP1A1CYP1B1 | |
| SCHEMBL24046880 | 0.71 | CSNK2A2 (0.55) | CSNK2A2CSNK2BCSNK2A1CYP1A1CYP1B1 | |
| SCHEMBL24046882 | 0.71 | CSNK2A2 (0.54) | CSNK2A2CSNK2BCSNK2A1CYP1A1CYP1B1 | |
| SCHEMBL24046876 | 0.71 | CSNK2A2 (0.54) | CSNK2A2CSNK2BCSNK2A1CYP1A1CYP1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021236578-A1 | CHROMEN-4-ONE DERIVATIVES, SUCH AS E.G. FLAVONES, FOR USE AS CK2 INHIBITORS FOR THE TREATMENT OF NEUROINFLAMMATION | SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2021-11-25 | — | — | WO | disclosed |